Clearpoint Neuro Inc (CLPT)

R&D to Revenue

42.57%

Quarterly · Period ending:

CLPT logo

CLPT R&D to Revenue

Latest reported42.57%
CLPT Quarterly R&D/Revenue (146.44% → 42.57%)
High-resolution chart · PNG

CLPT r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Clearpoint Neuro Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
42.5735%
37.2856%
31.0951%
38.9572%
41.5518%
39.8232%
42.8774%
40.8151%
39.7048%
34.3631%
38.9427%
42.1555%
60.5882%
55.6415%
70.0425%
51.574%
46.3654%
57.6625%
63.8487%
56.8649%
62.2033%
38.7841%
49.1095%
32.4808%
32.7684%
26.2516%
27.349%
26.0253%
26.7727%
23.6415%
21.1416%
34.1575%
40.4116%
33.654%
34.6651%
34.3443%
54.8684%
27.7867%
32.3963%
42.7715%
67.9369%
47.1398%
34.5729%
38.5323%
51.7028%
52.2081%
73.7311%
137.9281%
75.5673%
99.4031%
58.1707%
78.2035%
131.8812%
61.0231%
39.4734%
50.6757%
44.8459%
70.3744%
96.0194%
78.7868%
146.4431%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.